Although there are very few clinical studies published on the topic, the evidence summarized in Table 4 suggests that daily intake of NAC at doses between 0.6–1 g is able to improve liver enzymes such as ALT and AST in patients with NAFLD. This evidence concerns the gene NLRP1 and metabolic dysfunction-associated steatotic liver disease.